Financial reports - Theratechnologies, TSX TH, Tesamorelin, Lipohypertrophy, Lipodystrophy treatment

Model and picture are being used for illustrative purposes only.

Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investors

2008 Annual Report

2008 Annual Report

2008 Annual Report - COMPLETE (PDF: 964 Kb)
2008 Highlights and Corporate Overview (PDF: 672 Kb)
Chairman’s Letter (PDF: 96 Kb)
Message from the President and CEO (PDF: 304 Kb)
Management’s Discussion and Analysis (PDF: 232 Kb)
Consolidated Financial Statements (PDF: 284 Kb)
Consolidated Financial Statements (MS Excel: 52 Kb)

Terms of use